Author:
Vaschetto Rosanna,Clemente Nausicaa,Pagni Aline,Esposito Teresa,Longhini Federico,Mercalli Francesca,Boggio Elena,Boldorini Renzo,Chiocchetti Annalisa,Dianzani Umberto,Navalesi Paolo
Subject
Hematology,Immunology,Immunology and Allergy
Reference41 articles.
1. Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group;Abraham;Lancet,1998
2. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients;Abraham;Crit. Care Med.,2001
3. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome;Acute Respiratory Distress Syndrome Network;N. Engl. J. Med.,2000
4. Intravenous immunoglobulin for treating sepsis and septic shock;Alejandria;Cochrane Database Syst. Rev.,2002
5. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock;Alejandria;Cochrane Database Syst. Rev.,2013
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献